According to an analysis of gene expression data from The Cancer Genome Atlas and Genotype‐Tissue Expression project, the mRNA level of TDO2 is upregulated in ovarian serous cystadenocarcinoma in comparison to normal tissue, and higher TDO2 expression resulted in cancer progression.32 This evidence concerns the gene TDO2 and ovarian serous cystadenocarcinoma.